BETRFBETTERLIFE PHARMA INC.

About BETTERLIFE PHARMA INC. (BETRF)

BETTERLIFE PHARMA INC. (BETRF) is a Biotechnology company headquartered in VANCOUVER, BC, Canada whose shares trade over-the-counter on the OTCQB tier.

BetterLife Pharma Inc. is an emerging biotechnology company primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders.

Products and services

BETR-001, which is in preclinical and IND-enabling studies, is a non-hallucinogenic and non- controlled LSD derivative in development and it is unique in that it is unregulated and therefore can be self-administered. BetterLife’s synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent, for composition and method of use, covers treatment of major depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders. BETR-002, which is in preclinical and IND-enabling studies, is based on honokiol, the active anxiolytic ingredient of magnolia bark. BetterLife’s pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency. BetterLife also owns a drug candidate for the treatment of viral infections and is in the process of seeking strategic alternatives for further development.

BETRF key facts

Ticker symbol

BETRF

Market tier

OTCQB

Sector

Healthcare

Industry

Biotechnology

Headquarters

VANCOUVER, BC, Canada

Country of incorporation

CA

Year of incorporation

2002

Employees

4

Estimated market cap

$8.36M (as of Apr 11, 2025)

Shares outstanding

130,115,717

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

1/31

BETTERLIFE PHARMA INC. leadership

• Ahmad Doroudian — CEO
• Hooshmand Sheshbaradaran — COO
• Moira Ong — CFO, Principal Acct. Officer
• Accounts Payable — Other
• David Melles — Other

Explore more: Biotechnology stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with B